Fluoroquinolones as a trigger for rupture of abdominal aortic aneurysm: A case-crossover analysis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

17 Downloads (Pure)


Fluoroquinolones (FQ) are associated with an increased risk of tendinopathy, including rupture. Our study aimed to investigate whether FQ use triggered the rupture of aortic aneurysms using a self-controlled design. We hypothesised that the use of FQ was associated with aortic rupture shortly after redeemed FQ prescriptions. Using nationwide data sources, we performed a case-crossover study of cases with ruptured aortic aneurysms. From 1996 to 2016, 58 persons presented with rupture of an aortic aneurysm and a redeemed prescription for any FQ within 28 days. 67% were men, and the median age was 77 years. Some 82.9% presented with a ruptured abdominal aneurysm. In our conditional regression, the crude OR for having rupture with a recent FQ redemption was 1.36 (CI 1.00-1.86). After adjusting for potential confounders, the OR was 1.35 (CI 0.98-1.85). Changing the hazard period to FQ redemption within 60 and 90 days, the OR was 2.16 (CI 1.70-2.76) and 2.21 (CI 1.78-2.75), respectively. In conclusion, we demonstrated an association between FQ use within 60 and 90 days and a diagnosis of ruptured aortic aneurysm.

TidsskriftBasic & Clinical Pharmacology & Toxicology
Udgave nummer1
Sider (fra-til)44-51
StatusUdgivet - jul. 2021

Bibliografisk note

Funding Information:
KK was supported by a grant from the Department of Clinical Research at the University of Southern Denmark. The University of Southern Denmark is thanked for the financial support but did not influence the execution, analyses, or writing of the study.


Dyk ned i forskningsemnerne om 'Fluoroquinolones as a trigger for rupture of abdominal aortic aneurysm: A case-crossover analysis'. Sammen danner de et unikt fingeraftryk.